Association Between MRI Background Parenchymal Enhancement and Lymphovascular Invasion and Estrogen Receptor Status in Invasive Breast Cancer

Objectives: In magnetic resonance imaging (MRI), background parenchymal enhancement (BPE) is associated with breast cancer risk, but the associations between BPE and clinical characteristics and histological features are unknown. This study aimed to investigate the association between BPE and clinical characteristics (including age, menopausal status, and tumor histological characteristics) in patients with invasive breast cancer.

Methods: This was a retrospective study of 163 patients with invasive breast cancer (164 lesions, 1 patient had bilateral cancer) confirmed by surgery and pathological examination, treated between January 2014 and December 2016 at our university (Kunming Medical University). The patients were divided into two groups: extremely minimal and mild enhancement (low BPE group, = 78) moderate and marked enhancement (high BPE group, = 86).

Results: Compared with the low BPE group, the high BPE group showed higher frequencies of patients < 50 years of age (88% 38%, < 0.0001), premenopausal (87% 29%, < 0.0001), T1 staging (35% 15%, = 0.027), Grade II (57% 37%, = 0.03), lymphovascular invasion (83% 13%, < 0.0001), and positive estrogen receptor (ER) (79% 42%, < 0.0001). The Spearman correlation coefficients (r) between BPE and age, menopausal status, lymphovascular invasion, and ER status were -0.521 ( < 0.0001), -0.588 ( < 0.0001), 0.697 ( < 0.0001), and 0.377 ( < 0.0001), respectively.

Conclusion: BPE is negatively associated with age and menopausal status, and is positively associated with lymphovascular invasion and positive ER status.

Advances In Knowledge: BPE is not correlated with T staging and histological classification in patients with invasive breast cancer.